상세 보기
Three-year follow-up of PHASE 1 first-in-human Surovatamig, a CD19xCD3 T-cell engager, in R/R follicular lymphoma
- Rule, Simon;
- Hou, Jing-Zhou;
- Kim, Tae Min;
- Cho, Seok-Goo;
- Gaballa, Sameh;
- ... Kim, Won-Seog;
- 외 20명
Citations
WEB OF SCIENCE
0- 제목
- Three-year follow-up of PHASE 1 first-in-human Surovatamig, a CD19xCD3 T-cell engager, in R/R follicular lymphoma
- 저자
- Rule, Simon; Hou, Jing-Zhou; Kim, Tae Min; Cho, Seok-Goo; Gaballa, Sameh; Nair, Ranjit; Izutsu, Koji; Devata, Sumana; Yoon, Dok Hyun; Kim, Won-Seog; Sawalha, Yazeed; Jacobs, Ryan; Hawkes, Eliza; Wang, Ming-Chung; Tam, Constantine; Stevens, Don; Yokoyama, Hisayuki; Kim, Jin Seok; Matasar, Matthew; Ramakrishnan, Aravind; Brennan, Denise; Sermer, David; Lesley, Robin; Obrocea, Mihail; Chen, Robert; Maruyama, Dai
- 발행일
- 2026-04
- 유형
- Meeting Abstract
- 권
- 208
- 페이지
- S81 ~ S81